scPharmaceuticals’ (SCPH) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of scPharmaceuticals (NASDAQ:SCPH – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a $18.00 target price on the stock. scPharmaceuticals Stock Down 0.3 % Shares of NASDAQ SCPH opened at $3.00 on Thursday. The stock has a market […]
